ComplianceOnline
News
Best Practices
Compliance Training
Store
Q&A
BII
Welcome,
Guest
Free Registration | Sign In
ComplianceOnline Home > Compliance Training > FDA Training
 Sub Categories .
- FDA Audit and Inspection
- GXP Pharmaceutical
- GXP Medical Devices
- Drug and Device Approvals
- FDA Validation
- FDA 21 CFR Part 11
- Drug Marketing Compliance

Best practices for creating a Risk Management File

This Risk Management webinar/training will explain how to integrate risk management in to the quality management system.
Training Options Training Duration = 60 Min
$299.00 Access Recorded Version Only
One Person - Unlimited viewing for 6 Months
(For multiple licenses contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section
$500.00 Get Training CD Only
One CD is for usage in one location only.
(For multiple locations contact Customer Care)
CD and Ref. material will be shipped within 15 business days
 
Instructor: Dennis Moore
Product ID: 701445
Training Level: Intermediate to Advanced
Bookmark
 Tell a Friend
Description

Why Should You Attend :
Many companies are confident that their risk management process is compliant “enough” to the Quality System Regulation, yet FDA conducts an inspection and FDA 483 cites are written and Warning Letters, seizures or worse ensue. Internal audits show the firm meets FDA risk analysis requirements, yet FDA writes the firm up.

This presentation will review processes for integrating a reasonable level of risk management into the quality management system. Much emphasis will be placed during the talk on the risk management elements of the design control regulation, along with CAPA risk management concepts.Actual FDA investigator training methods related to specification holder inspections will be discussed Real life examples of FDA compliance issues will be examined.

Areas Covered in the Seminar:

  • How do I create an adequate Risk Management File?
  • How do I answer an FDA 483 cite?
  • Key mistakes in auditing practices.
  • Just what level of control does FDA have over this area.
  • How do I beat back a FDA 483 point.
  • How I do gain ISO 14971 compliance.

Who will benefit:

This webinar will provide your firm with key insights on how to identify compliance gaps in your risk management processes. The webinar will help you avoid FDA 483's and warning letters the employees who will benefit include:
  • Regulatory Managers
  • QA managers and personnel
  • RA managers
  • Quality Engineers
  • Internal auditors
  • Consultants

Instructor Profile:
Dennis M. Moore, is the President CEO and Founder of AUK Technical Services LTD (ATS). a worldwide consulting firm which specializes in Quality Systems and submissions for medical device and pharmaceutical companies. Mr. Moore is a former 22 year FDA credentialed Government investigator, Retired Peace Officer and author of many articles on quality system concepts. Mr. Moore has performed hundreds of FDA device and drug inspections, and written many FDA 483 and warning letter citations. He also has industry experience on the manufacturer side of the auditing desk.

Bookmark and Share
Refund Policy
 Customer Care
Call  +1-650-620-3937
Fax  +1-650-963-2556
Email  editor@complianceonline.com
Read Frequently Asked Questions
 
 Training Finder
   Find Trainings by Category
Find
 More Training by Dennis Moore
What will FDA expect and request from your firm during Design Control portions of Inspections?
Key differences in Design Control Requirements between ISO13485:2003 and the FDA Quality System Regulation
How to successfully audit software systems, and thereby avoid having FDA write software-related 483's and warning letters
Understanding the new International and FDA accepted Software Development Standard IEC 62304
 Customer Testimonials
This training hasn't been reviewed yet.